COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,899 Articles (22,568 medRxiv, 8,331 bioRxiv)

Most recent first Previous |  Page 450: Articles 4491-4500  | Next

Characteristics and outcomes of 7620 Multiple Sclerosis patients admitted with COVID-19 in the United States
Ramphul, K., Sombans, S., Verma, R., Lohana, P., Dhillon, B. K., Mejias, S. G., Sanikommu, S., Ramphul, Y., Pekyi-Boateng, P. K.
10.1101/2023.02.15.23285994 — Posted: 2023-02-16
Estimates of protection against SARS-CoV-2 infection and severe COVID-19 in Germany before the 2022/2023 winter season - the IMMUNEBRIDGE project
Lange, B., Jaeger, V. K., Harries, M., Ruecker, V., Streeck, H., Blaschke, S., Petersmann, A., Toepfner, N., Nauck, M., Hassenstein, M. J., Dreier, M., von Holt, I., Budde, A., Bartz, A., Ortmann, J., Kurosinski, M.-A., Berner, R., Borsche, M., Brandhorst, G., Brinkmann, M., Budde, K., Deckena, M., Engels, G., Fenzlaff, M., Haertel, C., Hovardovska, O., Katalinic, A., Kehl, K., Kohls, M., Krueger, S., Lieb, W., Meyer-Schlinkmann, K. M., Pischon, T., Rosenkranz, D., Ruebsamen, N., Rupp, J., Schaefer, C., Schattschneider, M., Schlegtendal, A., Schlinkert, S., Schmidbauer, L., Schulze-Wundling, K
10.1101/2023.02.16.23285816 — Posted: 2023-02-16
COVID-19 Vaccine Acceptance in Nigeria: A Rapid Systematic Review and Meta-Analysis
Nnaemeka, V. C., Okafor, N. A., Orababa, O. Q., Anikwe, R., Onwe, R. O., Uzochukwu, N. P., Tsiterimam, T. S., Nwokoye, N. N., Ike, A. C.
10.1101/2023.02.16.23286008 — Posted: 2023-02-16
Construction of Fosmid-based SARS-CoV-2 replicons for antiviral drug screening and replication analyses in biosafety level 2 facilities
Takazawa, S., Kotaki, T., Nakamura, S., Utsubo, C., Kameoka, M.
10.1101/2023.02.15.528742 — Posted: 2023-02-16
Factors associated with adverse outcomes among patients hospitalized at a COVID-19 treatment center run by Medecins sans Frontieres in Herat, Afghanistan
klein, A., Bastard, M., Hemat, H., Singh, S., Muniz, B., Manangama, G., Alayyan, A., Tamanna, A. H., Barakzaie, B., Popal, N., Kakar, M. A. Z., Poulet, E., Finger, F.
10.1101/2023.02.15.23285976 — Posted: 2023-02-16
Evolution of Life-Threatening COVID-19 as the SARS-CoV-2 Pandemic Has Progressed
Murthy, S. C., Lowry, A. M., Gordon, S. M., Blackstone, E. H.
10.1101/2023.02.15.23285759 — Posted: 2023-02-16
The role of serum brain injury biomarkers in individuals with a mild-to-moderate COVID infection and Long-COVID - results from the prospective population-based COVI-GAPP study
Telser, J., Grossmann, K., Weideli, O. C., Hillmann, D., Aeschbacher, S., Wohlwend, N., Velez, L., Kuhle, J., Maleska, A., Benkert, P., Risch, C., Conen, D., Risch, M., Risch, L.
10.1101/2023.02.15.23285972 — Posted: 2023-02-16
Adaptive metrics for an evolving pandemic: A dynamic approach to area-level COVID-19 risk designations
Bilinski, A., Salomon, J. A., Hatfield, L. A.
10.1101/2023.02.15.23285969 — Posted: 2023-02-16
Indian COVID-19 Preprints Submissions in bioRxiv and medRxiv Preprint Servers
Raju, V., Adakawa, M. I., Harinarayana, N. S., Yelemalla, C.
10.1101/2023.02.14.23285870 — Posted: 2023-02-16
Post-COVID syndrome is associated with capillary alterations, macrophage infiltration and distinct transcriptomic signatures in skeletal muscles
Aschman, T., Wyler, E., Baum, O., Hentschel, A., Legler, F., Preusse, C., Meyer-Arndt, L., Buettnerova, I., Foerster, A., Cengiz, D., Teixeira Alves, L. G., Schneider, J., Kedor, C., Rust, R., Bellmann-Strobl, J., Sanchin, A., Vajkoczy, P., Goebel, H.-H., Landthaler, M., Corman, V., Roos, A., Heppner, F. L., Radbruch, H., Paul, F., Scheibenbogen, C., Stenzel, W., Dengler, N. F.
10.1101/2023.02.15.23285584 — Posted: 2023-02-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).